Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Maria Vittoria Dieci, MD of the University of Padua, Padova, Italy, discusses the ROXANE study, an Italian prospective study evaluating the impact of the 21-gene recurrence score results on adjuvant treatment decisions for patients with early breast cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).